Publications

The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Levy AR, Stock D, Paterson JM, Tamim H, Chateau D, Quail J, Ronksley PE, Carney G, Reynier P, Targownik L, for the Canadian Network for Observational Drug Effect Studies (CNODES). Prescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis. CMAJ Open. 2023;11(6):E1033-E1040.

Azoulay L, St-Jean A, Dahl M, Quail J, Aibibula W, Brophy JM, Chan AW, Bresee L, Carney G, Eltonsy S, Tamim H, Paterson JM, Platt RW, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study. J Am Acad Dermatol. 2023;89(2):243-253.

Sinyavskaya L, Renoux C, Durand M. Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):105-109.

Sketris IS, Traynor RL, Helwig M, Burland E, Stewart SA. Exploring female parity in pharmacoepidemiology authorship: A case study of the Canadian Network for Observational Drug Effect Studies and its citing articles. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):82-90.

Nakhlé G, Brophy JM, Renoux C, Khairy P, Bélisle P, LeLorier J. Domperidone Increases Harmful Cardiac Events in Parkinson’s Disease: A Bayesian Re-Analysis of an Observational Study. J Clin Epidemiol.2021 Dec;140:93-100.

Sinyavskaya L, Schnitzer M, Renoux C, Guertin JR, Talbot D, Durand M. Evidence of the different associations of prognostic factors with censoring across treatment groups and impact on censoring weight model specification: the example of anticoagulation in atrial fibrillation. Am J Epidemiol. 2021 Dec 1;190(12):2671-2679.

Dormuth CR, Fisher A, Hudson M, Austin PC, Ernst P, Bresee L, Chateau D, Tamim H, Paterson JM, Lafrance JP, Taylor-Gjevre RM, Platt RW, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Impact of concomitant conventional DMARD on persistence of biologic DMARDS in rheumatoid arthritis: multi-centre, population-based cohort study. Seminars in Arthritis and Rheumatism. 2021 Dec;51(6):1291-1299.

Masarwa R, Lefebvre C, Platt RW, Filion KB. General Practitioner Prescribing Trends among Pediatric Patients in the United Kingdom: 1998-2018. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):302-313.

 

Ou LB; Moriello C; Douros A; Filion KB. Domperidone and the Risks of Sudden Cardiac Death and Ventricular Arrhythmia: A Systematic Review and Meta-Analysis of Observational Studies. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2021 oct;87(10):3649-3658.

Van den Ham HA, Souverein PC, Klungel OH, Platt RW, Ernst P, Dell’Aniello S, Schmiedl S, Rottenkolber M, Huerta C, Martín Merino E, León-Muñoz LM, Montero D, Andersen M, Aakjær M, De Bruin M, Gardarsdottir H. Major bleeding in users of direct oral anticoagulants in atrial fibrillation: a pooled analysis of results from multiple population-based cohort studies. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1339-1352.